Immunosuppressants-ligands as neuroprotectants.
Kelly
J S
JS
Fujisawa Institute of Neuroscience, Edinburgh, UK.
Sharkey
J
J
D002544:Cerebral Infarction / Q000188:drug therapy / Q000503:physiopathology; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008024:Ligands; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy / Q000503:physiopathology*; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D008024:Ligands; D018696:Neuroprotective Agents; D016572:Cyclosporine; D016559:Tacrolimus